SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001377
Filing Date
2022-05-12
Accepted
2022-05-12 16:43:19
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220331x10q.htm   iXBRL 10-Q 730423
2 EX-31.1 tmb-20220331xex31d1.htm EX-31.1 16232
3 EX-31.2 tmb-20220331xex31d2.htm EX-31.2 16218
4 EX-32.1 tmb-20220331xex32d1.htm EX-32.1 8744
5 EX-32.2 tmb-20220331xex32d2.htm EX-32.2 8519
  Complete submission text file 0001410578-22-001377.txt   3249417

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220331.xsd EX-101.SCH 24560
7 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 15794
8 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 90588
9 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 241340
10 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 185877
42 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331x10q_htm.xml XML 447156
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41264 | Film No.: 22918560
SIC: 2834 Pharmaceutical Preparations